| Name | Cvs Pharmacy #16711 |
|---|---|
| Organization Name | Cvs Pharmacy Inc |
| Location | 1001 E 120th Ave, Thornton, Colorado 80233 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (303) 280-6273 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Physicians are challenged in treating heart patients who may be at high-risk for gastrointestinal bleeding from aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs). Factors that place patients at high-risk include a history of ulcers or gastrointestinal complications such as bleeding, increased age and congestive heart failure.
The problem with antibiotics is that, eventually, bacteria outsmart them and become resistant. But by targeting the gene that confers such resistance, a new drug may be able to finally outwit them.
"Ten years ago today President Bush stepped into the Rose Garden to announce a $500 million program to stop the transmission of HIV passed from mothers to children during birth," an announcement that "led the way to PEPFAR," which Bush announced in his 2003 State of the Union address, John Donnelly, correspondent for GlobalPost's "Global Pulse" blog, writes in this commentary in the blog.
BioSante Pharmaceuticals, Inc. today announced that development of its GVAX Prostate Cancer Vaccine (GVAX Prostate) for the treatment of prostate cancer has been reinitiated. Manufacturing of new GVAX Prostate is in process, regulatory steps to lift the GVAX Prostate clinical hold prior to trial initiation are being taken, and prostate cancer patients are expected to be treated in a Phase II human clinical trial beginning in the fourth quarter of 2010 at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center.
Scientists at the Centre for Genomic Regulation in Barcelona, Spain, have joined today the Global City Sampling Day for the MetaSub research project. Started in 2013 in New York and led by Dr. Christopher E Mason at Weill Cornell Medicine, MetaSub is an international consortium of laboratories to establish a world-wide "DNA map" of microbiomes in mass transit systems.
› Verified 1 days ago
| NPI Number | 1073535779 |
| Organization Name | CVS PHARMACY INC. |
| Doing Business As | CVS PHARMACY #16711 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1001 E 120th Ave, Thornton, CO 80233 |
| Phone Number | 303-280-6273 |
News Archive
Physicians are challenged in treating heart patients who may be at high-risk for gastrointestinal bleeding from aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs). Factors that place patients at high-risk include a history of ulcers or gastrointestinal complications such as bleeding, increased age and congestive heart failure.
The problem with antibiotics is that, eventually, bacteria outsmart them and become resistant. But by targeting the gene that confers such resistance, a new drug may be able to finally outwit them.
"Ten years ago today President Bush stepped into the Rose Garden to announce a $500 million program to stop the transmission of HIV passed from mothers to children during birth," an announcement that "led the way to PEPFAR," which Bush announced in his 2003 State of the Union address, John Donnelly, correspondent for GlobalPost's "Global Pulse" blog, writes in this commentary in the blog.
BioSante Pharmaceuticals, Inc. today announced that development of its GVAX Prostate Cancer Vaccine (GVAX Prostate) for the treatment of prostate cancer has been reinitiated. Manufacturing of new GVAX Prostate is in process, regulatory steps to lift the GVAX Prostate clinical hold prior to trial initiation are being taken, and prostate cancer patients are expected to be treated in a Phase II human clinical trial beginning in the fourth quarter of 2010 at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center.
Scientists at the Centre for Genomic Regulation in Barcelona, Spain, have joined today the Global City Sampling Day for the MetaSub research project. Started in 2013 in New York and led by Dr. Christopher E Mason at Weill Cornell Medicine, MetaSub is an international consortium of laboratories to establish a world-wide "DNA map" of microbiomes in mass transit systems.
› Verified 1 days ago
News Archive
Physicians are challenged in treating heart patients who may be at high-risk for gastrointestinal bleeding from aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs). Factors that place patients at high-risk include a history of ulcers or gastrointestinal complications such as bleeding, increased age and congestive heart failure.
The problem with antibiotics is that, eventually, bacteria outsmart them and become resistant. But by targeting the gene that confers such resistance, a new drug may be able to finally outwit them.
"Ten years ago today President Bush stepped into the Rose Garden to announce a $500 million program to stop the transmission of HIV passed from mothers to children during birth," an announcement that "led the way to PEPFAR," which Bush announced in his 2003 State of the Union address, John Donnelly, correspondent for GlobalPost's "Global Pulse" blog, writes in this commentary in the blog.
BioSante Pharmaceuticals, Inc. today announced that development of its GVAX Prostate Cancer Vaccine (GVAX Prostate) for the treatment of prostate cancer has been reinitiated. Manufacturing of new GVAX Prostate is in process, regulatory steps to lift the GVAX Prostate clinical hold prior to trial initiation are being taken, and prostate cancer patients are expected to be treated in a Phase II human clinical trial beginning in the fourth quarter of 2010 at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center.
Scientists at the Centre for Genomic Regulation in Barcelona, Spain, have joined today the Global City Sampling Day for the MetaSub research project. Started in 2013 in New York and led by Dr. Christopher E Mason at Weill Cornell Medicine, MetaSub is an international consortium of laboratories to establish a world-wide "DNA map" of microbiomes in mass transit systems.
› Verified 1 days ago
Safeway Pharmacy #0892 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3840 E 104th Ave, Thornton, Colorado 80233 Phone: (303) 255-0587 | |
Colorado Eye Center Llc Type: Medicare Supplier Location: 12450 York St, Thornton, Colorado 80241 Phone: (303) 452-2020 | |
Northbrook Hand Therapy Inc Type: Medicare Supplier Location: 8801 Fox Dr, Thornton, Colorado 80260 Phone: (303) 650-6878 | |
Cranial Technologies, Inc Type: Prosthetic/Orthotic Supplier Location: 9351 Grant St, Thornton, Colorado 80229 Phone: (844) 447-5894 | |
Cvs Pharmacy #16711 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1001 E 120th Ave, Thornton, Colorado 80233 Phone: (303) 280-6273 |